Clinical Trials Directory

Trials / Unknown

UnknownNCT02333721

Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer

Study on Long-term Outcome of Laparoscopic Spleen-Preserving D2 Lymphadenectomy With and Without No. 10 Lymph Node Dissection for Advanced Gastric Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
536 (estimated)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
10 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore the short-term, long-term and oncological outcomes of laparoscopic spleen-preserving No. 10 lymph node dissection in a left-sided approach for advanced middle or upper third gastric cancer not invading greater curvature.

Detailed description

A prospective randomized comparison of laparoscopic spleen-preserving No. 10 lymph node dissection for gastric cancer will be performed, to evaluate the short-term, long-term and oncological outcomes. The evaluation parameters are perioperative clinical efficacy, postoperative life quality, immune function and 3-year survival and recurrence rates.

Conditions

Interventions

TypeNameDescription
PROCEDURED2 lymphadenectomy including No. 10After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, Laparoscopic total gastrectomy with D2 lymphadenectomy including spleen-Preserving No. 10 Lymph Node Dissection will be performed with curative treated intent. The type of reconstruction will be selected according to the surgeon's experience and anastomotic procedure is performed extracorporeally using a mini-laparotomy
PROCEDURED2 lymphadenectomy excluding No. 10After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, Laparoscopic total gastrectomy with D2 lymphadenectomy excluding spleen-Preserving No. 10 Lymph Node Dissection will be performed with curative treated intent. The type of reconstruction will be selected according to the surgeon's experience and anastomotic procedure is performed extracorporeally using a mini-laparotomy

Timeline

Start date
2015-01-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2015-01-07
Last updated
2020-09-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02333721. Inclusion in this directory is not an endorsement.

Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer (NCT02333721) · Clinical Trials Directory